Insight

Jul 28, 2024, 10:32

How the gut microbiome may influence chemotherapy response in urothelial carcinoma

Cancer Research Communications shared a post on X about a recent paper by Laura Bukavina et al. titled “Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation” published in AACR Journals.

Authors: Laura Bukavina, Rashida Ginwala, Mohamed Eltoukhi, Mohit Sindhani, Megan Prunty, Daniel Geynisman, Pooja Ghatalia et al.

chemotherapy

“Want to learn more about the gut microbiome in bladder cancer? This study provides important insights into how the gut microbiome may influence chemotherapy response in urothelial carcinoma.”

Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared this post, adding:

“We are very excited to keep pushing the field of microbiome… now with prospective trials, intravesical therapy and FMT! More to come.”

Source: Cancer Research Communications/X and Laura Bukavina/X

AACR Journals bladder cancer cancer Cancer Research Communications Case Western Reserve University chemotherapy Daniel Geynisman intravesical therapy Laura Bukavina Megan Prunty Mohamed Eltoukhi Mohit Sindhani OncoDaily Oncology Pooja Ghatalia Rashida Ginwala

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer